Thermonobodies: A Novel Thermostable FN3 Binding Protein Scaffold

Inventor(s):

    SUMMARY

    • Monobodies are synthetic binding proteins based off a human fibronectin type 3 (FN3) scaffold that have demonstrated their utility in applications such as the modification of enzyme specificity and therapeutics for topologically challenging targets. Thermostability limits shelf life, oral bioavailability in therapeutic applications, and high temperature industrial reaction engineering applications. 
    • “TherMonobodies” are Monobodies engineered from a hyperthermophillic archaeon FN3 scaffold with further structural modifications to boost thermostability over the original human FN3 scaffold
    • TherMonobody libraries have been engineered with: 1) a loop-based diversity for recognition of cleft-like epitopes protruding from the target and 2) a side-and-loop based diversity for recognition of a more continuous surface on the target. The scaffold is engineered for favorable expression in both the yeast and phage display formats.
    • In a proof-of-concept study both loop and side-and-loop TherMonobody libraries were screened against ySUMO, MBP, GFP, Abl SH2, SHP2 N-, and C-SH2 model targets. The resulting clones had Tms ranging from 50°C-86°C, a 13°C increase over the original Monobody scaffold.

     

    FIGURE

    Thermostability curves of select proof-of-concept TherMonobody clones as measured by differential scanning fluorimetry (DSF).

     

    ADVANTAGES

    ADVANTAGES

    • Increased thermostability over traditional Monobodies
    • Ten-fold smaller than traditional antibodies
    • Alternate binding mechanism from other immunoglobins is amenable to topologically challenging targets

     

    APPLICATIONS

    • Industrial reaction engineering and catalysis
    • Diagnostics
    • Research tools

     

    PUBLICATIONS

    • TherMonobides, synthetic binding proteins based on a hyperthermophillic fibronectin type III domain. Tanka, et al. In preparation.

     

    • PCTUS2019/018866.
    • For more information on enzyme modification with Monobodies, see also: Novel Platform for Allosterically Modifying Enzyme Specificity (14-T-118)

    TECH DETAILS

    Published
    1/7/2020

    Reference ID
    16-T-034

    Have Questions?

    Michael Hinton

    Contact Michael Hinton, Senior Manager, Technology Marketing, who can provide more detail about this technology, discuss the licensing process, and connect you with the inventor.

    This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

    Accept
    [%Analytics%]